Prohledat tento blog

Delaying ADT Safe for Prostate Cancer Patients | Cancer Network





Delaying ADT Safe for Prostate Cancer Patients | Cancer Network



The estimated 5-year overall survival among the group of men who had delayed ADT was 87.2% compared with 85.1% for those who had immediate ADT following a PSA-based relapse. Ten-year survival was 71.6% for both groups.
The prostate cancer-specific mortality was also similar for the two groups: the 5-year survival for the immediate and delayed ADT groups was 96% and 93.3%, respectively, and the 10-year survival was 90.2% and 89.4%, respectively. All of the patients were previously treated with radical prostatectomy or radiotherapy......




....
Enhanced by Zemanta

Hormonální léčba

Archiv blogu